CHC News View All Carter: CHC Plays Vital Role in Protecting our Industry 03, 24, 2022 Read more Webinar: Biden Year Two, the 50/50 Senate, Looming Midterms: What Will Health Policy Look Like in 2022? 01, 21, 2022 Read more Rising Leaders Conference Set for Nov. 18-19: Reserve Your Place Today! 03, 12, 2020 Read more Courts/First Amendment View All Federal Court Ruling on ACA Provision Could Have Broad Implications for Preventive Care 09, 13, 2022 Read more ACA Survives SCOTUS Scrutiny, Latest in “String of Victories” 06, 17, 2021 Read more Maryland Sued Over Digital Ad Tax 02, 19, 2021 Read more DTC Advertising View All OPDP To Study Medication Adherence Claims 10, 04, 2022 Read more Presentation of Risks in DTC Video, HCP Webpage Yields Enforcement Letter for Bausch Health 04, 18, 2022 Read more OPDP Cites Lilly for Omission of Risk Info in Trulicity Instagram Post 01, 31, 2022 Read more General View All 2023 ACA Enrollment on Course to Surpass 2022 Record 11, 29, 2022 Read more Clinical Trials Not Sufficiently Diverse – and Diversity Data Often Not Reported 05, 09, 2022 Read more HHS: Pharmacists Can Administer COVID-19 Antivirals 11, 29, 2021 Read more Legislative View All Will Pasteur Act Finally Pass During Lame-duck Session? 11, 14, 2022 Read more Inflation Reduction Act Includes Drug Price Restrictions, but Is Limited in Scope 08, 15, 2022 Read more Could Burr’s New User Fee Bill Lead to Timely Passage of Legislation? 07, 18, 2022 Read more Off-label Promotion View All Bad Ad Program Yields Two OPDP Enforcement Letters on Risk, Safety Information 10, 19, 2018 Read more House Bill on Sharing Certain Information about Investigational Products Moves Forward 01, 22, 2018 Read more House Subcommittee Considers Two Off-label Bills 07, 14, 2017 Read more Regulatory/FDA View All FDA Accelerated Approval Program Is Under Spotlight Again with Makena 10, 28, 2022 Read more OPDP: Risk, Efficacy Claims for Cholesterol Drug in Doctor Promotion Are False/Misleading 06, 27, 2022 Read more HHS Formally Withdraws SUNSET Final Rule 06, 20, 2022 Read more Washington Focus View All FDA Funding Hangs in the Balance as Congress Struggles with FY 2023 Budget, User Fee Reauthorization 08, 30, 2022 Read more Medicare Advantage Plans May Promise More but Deliver Less 05, 02, 2022 Read more Biden’s 2023 Budget: Big Increases for FDA, CDC, Pandemic Preparedness 04, 04, 2022 Read more
